版本:
中国

BRIEF-Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in US

March 8 Celyad SA:

* Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐